HANGZHOU TIGERMED CONSULTING CO LTD revenue breakdown overview

HANGZHOU TIGERMED CONSULTING CO LTD revenue for the last year amounted to 7.07 B HKD, the most of which — 3.57 B HKD — came from its highest performing source at the moment, Clinical Trial Related Services and Laboratory Services, the year earlier bringing 3.45 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought HANGZHOU TIGERMED CONSULTING CO LTD 3.85 B HKD, and the year before that — 4.68 B HKD.